As of Friday close, GoodRx Holdings Inc.’s (NASDAQ:GDRX) stock was up $0.45, moving up 6.80 percent to $7.07. The average number of shares traded per day over the past five days has been 2,139,380 shares. 4 times new highs have been achieved over the past 5 days, with a $0.84 gain in that time frame. In the last twenty days, the average volume was 1,405,750, while in the previous 50 days, it was 1,720,162.
Since last month, GDRX stock rose 5.84%. Shares of the company fell to $5.77 on 07/28/22, the lowest level in the past month. A 52-week high of $48.05 was reached on 01/03/22 after having rallying from a 52-week low of $5.61. Since the beginning of this year, GDRX’s stock price has dropped by -78.37% or -$25.61, and marked a new high 1 time. However, the stock has declined by -85.29% since its 52-week high.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
GoodRx Holdings Inc. (GDRX) last reported insider trading activity 215 days ago on Jan 03. Idea Men, LLC, the 10% Owner of the company, disposed of 2,600 shares for $33.05 on Jan 03. It resulted in a $85,927 divestment by the insider. Slutsky Andrew sold 35,829 shares at an average price of $32.40 on Jan 03. The insider now owns 2,884,529 shares following the transaction. On Dec 28, Chief Financial Officer Voermann Karsten sold 12,500 shares at $33.05 apiece. The transaction was valued at $413,182.
In the three months ended March 30, GoodRx Holdings Inc.’s quick ratio stood at 16.80, while its current ratio was 16.80, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending March 30 was 0.83, and the total debt-to-equity ratio was 0.84. On the profitability front, the trailing twelve-month gross margin is 93.80% percent. In the year ended March 30, operating margins totaled 4.80%. Based on annual data, GDRX earned $698.71 million in gross profit and brought in $745.42 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -0.10%. Return on equity (ROE) for the past 12 months was -1.80%.
In GoodRx Holdings Inc.’s quarter-end financial report for March 30, it reported total debt of $654.85 million. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. GDRX’s revenue rose 21.1% to $213.26 million during the quarter, while net income inched up to $203.33 million. While analysts expected GoodRx Holdings Inc. to report $0.08 quarterly earnings, the actual figure was $0.1 per share, beating the consensus estimate by 25.00%. During the quarter, the company generated $31.99 million in EBITDA. The liabilities of GoodRx Holdings Inc. were 751.82 million at the end of its most recent quarter ended March 30, and its total debt was $700.09 million. The value of shareholders’ equity is $396.46 million.
This quick technical analysis looks at GoodRx Holdings Inc.’s (GDRX) price momentum. With a historical volatility rate of 61.86%, the RSI 9-day stood at 64.99% on 05 August.
With respect to its five-day moving average, the current GoodRx Holdings Inc. price is up by +13.48% percent or $0.84. At present, GDRX shares trade +7.61% above its 20-day simple moving average and -48.09% percent below its 100-day simple moving average. However, the stock is currently trading approximately -5.73% below its SMA50 and -84.12% below its SMA200.
Stochastic coefficient K was 58.90% and Stochastic coefficient D was 43.15%, while ATR was 0.45. Given the Stochastic reading of 79.75% for the 14-day period, the RSI (14) reading has been calculated as 56.87%. As of today, the MACD Oscillator reading stands at 0.33, while the 14-day reading stands at 0.16.
GoodRx Holdings Inc. downgraded its rating on GoodRx Holdings Inc. (NASDAQ: GDRX) to a Neutral in a note to investors on June 10, 2022. The analysts firm previously had a Buy rating on the stock.GoodRx Holdings Inc. (GDRX) has been rated Hold by analysts. According to 1 brokerage firm, GDRX is a sell, and 13 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate GoodRx Holdings Inc. stock as buy, with 3 recommending it as overweight.
With a median target price of $9.00, the current consensus forecast for the stock is $6.00 – $13.00. Based on these forecasts, analysts predict GoodRx Holdings Inc. (GDRX) will achieve an average price target of $9.31.